Important advances in malaria vaccine research

作者: Priyanka Jadhav , Ritesh Shah , Manoj Jadhav , None

DOI: 10.4103/2229-5186.98676

关键词:

摘要: Malaria is one of the most widespread parasitic infection in Asian countries affecting poor poor. In an effort to develop effective vaccine for treatment malaria, various attempts are being made worldwide. If successful, such a can be both Plasmodium vivax and falciparum. This would also able avoid complications as drug resistance, resistance insecticides, nonadherence schedule, eventually high cost resource-limited settings. current compilation, details from literature were collected by using PubMed Medline search engines searched terms vaccine, malaria treatment. review collates provides glimpses information on recent development. The reader will taken through historical perspective followed approaches development pre-erythrocytic stage vaccines, asexual transmission blocking etc. Looking at scenario strategies, it absolute need hour that should developed. bring revolutionary breakthrough modalities especially when there increasing emergence existing therapy. It great purpose serve those living endemic region travelers which nonimmune coming region. As P. more prevalent India other subcontinent often prominent areas where elimination attempted, special consideration required role vaccines transmission, regardless stages targeted. Development feasible but with support private sector government organization regulatory importantly financially, expensive venture.

参考文章(124)
Nabarro D, Roll Back Malaria. Parassitologia. ,vol. 41, pp. 501- 504 ,(1999)
Elodie Belnoue, Fabio Costa, Tobias Frankenberg, Ana Margarida Vigário, Tatiana Voza, Nicolas Leroy, Mauricio M Rodrigues, Irene Landau, Georges Snounou, Laurent Rénia, Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. Journal of Immunology. ,vol. 172, pp. 2487- 2495 ,(2004) , 10.4049/JIMMUNOL.172.4.2487
Peter M Nyarango, Tewolde Gebremeskel, Goitom Mebrahtu, Jacob Mufunda, Usman Abdulmumini, Andom Ogbamariam, Andrew Kosia, Andemariam Gebremichael, Disanayike Gunawardena, Yohannes Ghebrat, Yahannes Okbaldet, None, A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods Malaria Journal. ,vol. 5, pp. 33- 33 ,(2006) , 10.1186/1475-2875-5-33
S. COHEN, I. A. McGREGOR, S. CARRINGTON, Gamma-Globulin and Acquired Immunity to Human Malaria Nature. ,vol. 192, pp. 733- 737 ,(1961) , 10.1038/192733A0
Sodiomon B Sirima, Alfred B Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C Bougouma, Amadou T Konaté, Youssouf Kaboré, Abdoulaye Traoré, Chilengi Roma, Issiaka Soulama, Adrian JF Luty, Simon Cousens, Issa Nébié, None, Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children PLoS ONE. ,vol. 4, pp. e7549- ,(2009) , 10.1371/JOURNAL.PONE.0007549
D. Doolan, N. Martinez-Alier, Immune response to pre-erythrocytic stages of malaria parasites Current Molecular Medicine. ,vol. 6, pp. 169- 185 ,(2006) , 10.2174/156652406776055249
Souraya Ramjanee, James S. Robertson, Blandine Franke-Fayard, Ria Sinha, Andrew P. Waters, Chris J. Janse, Yimin Wu, Andrew M. Blagborough, Allan Saul, Robert E. Sinden, The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials. Vaccine. ,vol. 25, pp. 886- 894 ,(2007) , 10.1016/J.VACCINE.2006.09.035
W. A. Siddiqui, L. Q. Tam, K. J. Kramer, G. S. Hui, S. E. Case, K. M. Yamaga, S. P. Chang, E. B. Chan, S. C. Kan, Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 3014- 3018 ,(1987) , 10.1073/PNAS.84.9.3014